176 related articles for article (PubMed ID: 19965663)
1. Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.
Bharadwaj AS; Kelly M; Kim D; Chao H
Blood; 2010 Jan; 115(3):500-9. PubMed ID: 19965663
[TBL] [Abstract][Full Text] [Related]
2. Induction of immune tolerance to FIX following muscular AAV gene transfer is AAV-dose/FIX-level dependent.
Kelly ME; Zhuo J; Bharadwaj AS; Chao H
Mol Ther; 2009 May; 17(5):857-63. PubMed ID: 19240690
[TBL] [Abstract][Full Text] [Related]
3. Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer.
Cohn EF; Zhuo J; Kelly ME; Chao HJ
J Thromb Haemost; 2007 Jun; 5(6):1227-36. PubMed ID: 17362228
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.
Ge Y; Powell S; Van Roey M; McArthur JG
Blood; 2001 Jun; 97(12):3733-7. PubMed ID: 11389010
[TBL] [Abstract][Full Text] [Related]
5. Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.
Cooper M; Nayak S; Hoffman BE; Terhorst C; Cao O; Herzog RW
Hum Gene Ther; 2009 Jul; 20(7):767-76. PubMed ID: 19309290
[TBL] [Abstract][Full Text] [Related]
6. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.
Cao O; Dobrzynski E; Wang L; Nayak S; Mingle B; Terhorst C; Herzog RW
Blood; 2007 Aug; 110(4):1132-40. PubMed ID: 17438084
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.
Zhang Y; Chirmule N; Gao Gp; Wilson J
J Virol; 2000 Sep; 74(17):8003-10. PubMed ID: 10933709
[TBL] [Abstract][Full Text] [Related]
8. Muscle as a target for supplementary factor IX gene transfer.
Hoffman BE; Dobrzynski E; Wang L; Hirao L; Mingozzi F; Cao O; Herzog RW
Hum Gene Ther; 2007 Jul; 18(7):603-13. PubMed ID: 17594244
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells and immune tolerance to coagulation factor IX in the context of intramuscular AAV1 gene transfer.
Kelly M; Bharadwaj AS; Tacke F; Chao H
Mol Ther; 2010 Feb; 18(2):361-9. PubMed ID: 19935782
[TBL] [Abstract][Full Text] [Related]
10. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
[TBL] [Abstract][Full Text] [Related]
12. Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity.
Martino AT; Nayak S; Hoffman BE; Cooper M; Liao G; Markusic DM; Byrne BJ; Terhorst C; Herzog RW
PLoS One; 2009 Aug; 4(8):e6376. PubMed ID: 19652717
[TBL] [Abstract][Full Text] [Related]
13. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
[TBL] [Abstract][Full Text] [Related]
14. Enhancing transduction of the liver by adeno-associated viral vectors.
Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
[TBL] [Abstract][Full Text] [Related]
15. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
Xin KQ; Mizukami H; Urabe M; Toda Y; Shinoda K; Yoshida A; Oomura K; Kojima Y; Ichino M; Klinman D; Ozawa K; Okuda K
J Virol; 2006 Dec; 80(24):11899-910. PubMed ID: 17005662
[TBL] [Abstract][Full Text] [Related]
16. Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B.
Arruda VR; Stedman HH; Haurigot V; Buchlis G; Baila S; Favaro P; Chen Y; Franck HG; Zhou S; Wright JF; Couto LB; Jiang H; Pierce GF; Bellinger DA; Mingozzi F; Nichols TC; High KA
Blood; 2010 Jun; 115(23):4678-88. PubMed ID: 20335222
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
18. Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector.
Mingozzi F; Schüttrumpf J; Arruda VR; Liu Y; Liu YL; High KA; Xiao W; Herzog RW
J Virol; 2002 Oct; 76(20):10497-502. PubMed ID: 12239326
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
20. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.
Sabatino DE; Mackenzie TC; Peranteau W; Edmonson S; Campagnoli C; Liu YL; Flake AW; High KA
Mol Ther; 2007 Sep; 15(9):1677-85. PubMed ID: 17565352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
